title: Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.
authors.forename: Javier
authors.initials: J
authors.lastname: de la Rubia
authors.forename: Mónica
authors.initials: M
authors.lastname: Roig
authors.forename: Angela
authors.initials: A
authors.lastname: Ibáñez
authors.forename: Inmaculada
authors.initials: I
authors.lastname: García
authors.forename: José A
authors.initials: JA
authors.lastname: Vera
authors.forename: Carlos
authors.initials: C
authors.lastname: Aguilar
authors.forename: Raquel
authors.initials: R
authors.lastname: del Campo
authors.forename: Nicolás
authors.initials: N
authors.lastname: González
authors.forename: Rafael
authors.initials: R
authors.lastname: Martínez
authors.forename: Luis
authors.initials: L
authors.lastname: Palomera
authors.forename: Isabel
authors.initials: I
authors.lastname: Picón
authors.forename: Juan N
authors.initials: JN
authors.lastname: Rodríguez
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Sanz
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006435:Renal Dialysis; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide